Skip to content
★ Sign in to follow
AM

Alastair MacKinnon

Mereo BioPharma Group plc
Total declarations
4
Company
1
▲ Purchases (2 ops.)
€1,094
▼ Sales (0 ops.)
—

Latest filing published 22 Nov 2019 for Mereo BioPharma Group plc.

Filing timeline

BuySale
Alastair MacKinnon

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Alastair MacKinnon: trading record in brief

Alastair MacKinnon is a declared insider of Mereo BioPharma Group plc, with filings sourced from SEC (Form 4). Over a trading history stretching from 21 May 2019 to 4 October 2019, the count stands at 4 filings.

The open-market record is one-sided, with 2 purchases worth €1,094 and not one sale. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants.

The record was last updated on 22 November 2019 with an open-market purchase in Mereo BioPharma Group plc. Typically, a trade is published a median of 25 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Alastair MacKinnon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    Chief Medical OfficerExecutivesMereo BioPharma Group plc
    0FCA-NSM
    15,169 shares@ €0.6634AIMXFCA-NSM:LSE20191122170953_14320409_20200326185146836_7768-1
    Canonical exit: 2 Jan 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesMereo BioPharma Group plc
    1,201 USD19FCA-NSM
    365 shares@ US$3.29100.0% of flowXNMSFCA-NSM:LSE20191122170953_14320409_20200326185146836_7768-2
    Canonical exit: 2 Jan 2020 (T+90)
  • ◆
    Chief Medical OfficerExecutivesMereo BioPharma Group plc
    0FCA-NSM
    27,500 sharesOutside of a trading venueFCA-NSM:LSE20190724100812_14161287_20200326185123408_10441-1
  • ◆
    Chief Medical OfficerExecutivesMereo BioPharma Group plc
    0FCA-NSM
    27,500 sharesOutside of a trading venueFCA-NSM:LSE20190521150839_14082298_20200326185142080_11482-1

4 of 4 declarations